HIV/AIDS

  1. Deep-sequence phylogenetics to quantify patterns of HIV transmission in the context of a universal testing and treatment trial – BCPP/Ya Tsie trial

    1. Lerato E Magosi
    2. Yinfeng Zhang
    3. Tanya Golubchik
    4. Victor DeGruttola
    5. Eric Tchetgen Tchetgen
    6. Vladimir Novitsky
    7. Janet Moore
    8. Pam Bachanas
    9. Tebogo Segolodi
    10. Refeletswe Lebelonyane
    11. Molly Pretorius Holme
    12. Sikhulile Moyo
    13. Joseph Makhema
    14. Shahin Lockman
    15. Christophe Fraser
    16. Myron Max Essex
    17. Marc Lipsitch
    18. On behalf of The Botswana Combination Prevention Project and PANGEA consortium

    • Curated by eLife

      Evaluation Summary:

      One hypothesis to explain recent worse-than-expected outcomes of universal test-and-treat HIV prevention trials is population mobility. The authors show phylogenetically that mobility could play a role in transmission events in a large trial in Botswana. This study is of public health interest, has a large sample size for a phylogenetic study in this setting, and overall precise analysis. A few methodological clarifications are still needed to ensure that the data supports the study's claims.

      (This preprint has been reviewed by eLife. We include the public reviews from the reviewers here; the authors also receive private feedback with suggested changes to the manuscript. Reviewer #1 agreed to share their name with the authors.)

    Reviewed by eLife

    4 evaluationsAppears in 1 listLatest version Latest activity

  2. People with HIV have a higher risk of COVID‐19 diagnosis but similar outcomes to the general population

    1. Michael E. Tang
    2. Thaidra Gaufin
    3. Ryan Anson
    4. Wenhong Zhu
    5. William C. Mathews
    6. Edward R. Cachay

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Systematic review and meta-analysis of COVID-19 vaccines safety, tolerability, and efficacy among HIV-infected patients

    1. Jacques L Tamuzi
    2. Ley M Muyaya
    3. Amal Mitra
    4. Peter S Nyasulu

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Time Between Viral Loads for People With HIV During the COVID-19 Pandemic

    1. Walid G. El-Nahal
    2. Nicola M. Shen
    3. Jeanne C. Keruly
    4. Joyce L. Jones
    5. Anthony T. Fojo
    6. Yukari C. Manabe
    7. Richard D. Moore
    8. Kelly A. Gebo
    9. Geetanjali Chander
    10. Catherine R. Lesko

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Safety and Immunogenicity of SARS-CoV-2 S-2P Protein Vaccine MVC-COV1901 in People Living with HIV

    1. Shu-Hsing Cheng
    2. Chia En Lien
    3. Szu-Min Hsieh
    4. Chien-Yu Cheng
    5. Wang-Da Liu
    6. Ching-Lung Lo
    7. Wen-Chien Ko
    8. Yen-Hsu Chen
    9. Ching-Tai Huang
    10. Hsiao-Ting Chang
    11. Shinn-Jang Hwang
    12. Ning-Chi Wang
    13. Ming-Che Liu
    14. Yu-Lin Lee
    15. I-Chen Tai
    16. Josue Antonio Garcia Estrada
    17. Tzou-Yien Lin
    18. Wen-Sen Lee

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. High seroconversion rate and SARS-CoV-2 Delta neutralization in people with HIV vaccinated with BNT162b2

    1. Valérie Pourcher
    2. Lisa Belin
    3. Cathia Soulie
    4. Michelle Rosenzwajg
    5. Stéphane Marot
    6. Karine Lacombe
    7. Nadia Valin
    8. Gilles Pialoux
    9. Ruxandra Calin
    10. Christia Palacios
    11. Isabelle Malet
    12. Karen Zafilaza
    13. Roland Tubiana
    14. Marc-Antoine Valantin
    15. David Klatzmann
    16. Vincent Calvez
    17. Noémie Simon-Tillaux
    18. Anne-Geneviève Marcelin

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Analysis of Postvaccination Breakthrough COVID-19 Infections Among Adults With HIV in the United States

    1. Sally B. Coburn
    2. Elizabeth Humes
    3. Raynell Lang
    4. Cameron Stewart
    5. Brenna C. Hogan
    6. Kelly A. Gebo
    7. Sonia Napravnik
    8. Jessie K. Edwards
    9. Lindsay E. Browne
    10. Lesley S. Park
    11. Amy C. Justice
    12. Kirsha S. Gordon
    13. Michael A. Horberg
    14. Julia M. Certa
    15. Eric Watson
    16. Celeena R. Jefferson
    17. Michael J. Silverberg
    18. Jacek Skarbinski
    19. Wendy A. Leyden
    20. Carolyn F. Williams
    21. Keri N. Althoff
    22. Corona-Infectious-Virus Epidemiology Team (CIVETs) of the NA-ACCORD of IeDEA

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Tenofovir Disoproxil Fumarate and severity of COVID-19 in people with HIV infection

    1. J Del Amo
    2. R Polo
    3. S Moreno
    4. E Martínez
    5. A Cabello
    6. JA Iribarren
    7. A Curran
    8. J Macías
    9. M Montero
    10. C Dueñas
    11. AI Mariño
    12. S Pérez de la Cámara
    13. A Díaz
    14. JR Arribas
    15. I Jarrín
    16. MA Hernán

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Factors Associated With Severity of COVID-19 Disease in a Multicenter Cohort of People With HIV in the United States, March–December 2020

    1. Adrienne E. Shapiro
    2. Rachel A. Bender Ignacio
    3. Bridget M. Whitney
    4. Joseph A. Delaney
    5. Robin M. Nance
    6. Laura Bamford
    7. Darcy Wooten
    8. Jeanne C. Keruly
    9. Greer Burkholder
    10. Sonia Napravnik
    11. Kenneth H. Mayer
    12. Allison R. Webel
    13. H. Nina Kim
    14. Stephen E. Van Rompaey
    15. Katerina Christopoulos
    16. Jeffrey Jacobson
    17. Maile Karris
    18. Davey Smith
    19. Mallory O. Johnson
    20. Amanda Willig
    21. Joseph J. Eron
    22. Peter Hunt
    23. Richard D. Moore
    24. Michael S. Saag
    25. W. Christopher Mathews
    26. Heidi M. Crane
    27. Edward R. Cachay
    28. Mari M. Kitahata
    29. for the CFAR Network of Integrated Clinical Systems

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Ad26.CoV2.S Vaccination in People Living With Human Immunodeficiency Virus (HIV)

    1. Khadija Khan
    2. Gila Lustig
    3. Mallory Bernstein
    4. Derseree Archary
    5. Sandile Cele
    6. Farina Karim
    7. Muneerah Smith
    8. Yashica Ganga
    9. Zesuliwe Jule
    10. Kajal Reedoy
    11. Yoliswa Miya
    12. Ntombifuthi Mthabela
    13. Nombulelo P Magula
    14. Richard Lessells
    15. Tulio de Oliveira
    16. Bernadett I Gosnell
    17. Salim Abdool Karim
    18. Nigel Garrett
    19. Willem Hanekom
    20. Linda-Gail Bekker
    21. Glenda Gray
    22. Jonathan M Blackburn
    23. Mahomed-Yunus S Moosa
    24. Alex Sigal
    25. COMMIT-KZN Team
    26. Adrie Steyn
    27. Alasdair Leslie
    28. Dirhona Ramjit
    29. Emily Wong
    30. Guy Harling
    31. Henrik Kloverpris
    32. Jackson Marakalala
    33. Janet Seeley
    34. Jennifer Giandhari
    35. Kaylesh Dullabh
    36. Kennedy Nyamande
    37. Kobus Herbst
    38. Kogie Naidoo
    39. Matilda Mazibuko
    40. Moherndran Archary
    41. Mosa Moshabela
    42. Nesri Padayatchi
    43. Nigel Klein
    44. Nikiwe Mbatha
    45. Nokuthula Ngcobo
    46. Nokwanda Gumede
    47. Nokwanda Ngcobo
    48. Philip Goulder
    49. Prakash Jeena
    50. Rajhmun Madansein
    51. Ravindra K. Gupta
    52. Rohen Harrichandparsad
    53. Samita Singh
    54. Thandeka Khoza
    55. Theresa Smit
    56. Thumbi Ndung'u
    57. Vinod Patel
    58. Zaza Ndhlovu

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 4 of 8 Next